Yes, it is true, many clinical trial results are not published, especially negative results. This is even true for FDA approved drugs and treatments! Failing to publish, or actually hiding negative results and harmful side effects that occur in clinical trials is too common and jeopardizes each and everyone of us, including survivors of advanced [...]
Below is an article that was posted by the National Journal on Tuesday on the omnibus bill that will likely pass Congress. Take note of the reference to NIH funding. “It is what we are spending tax dollars on, and where restraint is foolish and counterproductive. Funding for the National Institutes of Health is higher [...]
It is truly amazing and very shocking, from 1996 to 1999, the U.S. food and Drug Administration (FDA) approved 157 new drugs. Compared to the period of 2006 to 2009 the FDA approved 74 drugs. However, NOT one of these approved drugs provided a cure for any serious illness! Diseases that destroy lives, diseases like [...]
On June 27, 2009, Gina Kolata’s article in the New York Times on the too safe nature of funding from the National Institute of Health (NIH) struck a chord for many of us. She opens the article with the following, “Among the recent research grants awarded by the National Cancer Institute is one for a [...]
Senator Arlen Specter (D-PA) introduced S. 914, the Cures Acceleration Network and National Institutes of Health Reauthorization Act of 2009. The bill has three main components: 1. Establishes a new, independent federal agency, to be known as the “Cures Acceleration Network” (CAN), which would award grants and contracts to accelerate the development of cures and [...]
Many members of Congress see the potential of an increased investment in the NIH as part of the solution to our ailing economy. We prostate cancer survivors can glean additional benefits from an increase to NIH funding, in our fight against this terrible disease. The belief that making an increased economic investment in research through [...]
At this moment, the United States Congress is in session and actively considering an economic stimulus package. It is vital that we join together with many other cancer advocacy organizations and support the inclusion of the proposed $1.9 billion allocation to the National Institutes of Health (NIH), the federal agency that oversees cancer and other [...]
Today’s New York Times, in the Sunday opinion section, there was an editorial about the economic problems facing academic research institutions and their young researchers. The problems they are facing is a direct result of the flat budget that The National Institute of Health (NIH) has been given over the last five years. The rate [...]
